{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:27:23Z","timestamp":1755221243894,"version":"3.43.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2020FYCCE3"],"award-info":[{"award-number":["PRIN 2020FYCCE3"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.biopha.2025.118243","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T22:10:53Z","timestamp":1750198253000},"page":"118243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cabergoline counteracts adipose and skeletal muscle lipid accumulation: A novel therapeutic approach to obesity?"],"prefix":"10.1016","volume":"189","author":[{"given":"Mariarosaria","family":"Negri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Simona","family":"Auriemma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feliciana","family":"Amatrudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella Paola","family":"Provvisiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Patalano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Anna","family":"Marciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guendalina Del","family":"Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Menafra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Feliciello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Crescenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"360","key":"10.1016\/j.biopha.2025.118243_bib1","first-page":"1","article-title":"Prevalence of obesity and severe obesity among adults: United States, 2017-2018","author":"Hales","year":"2020","journal-title":"NCHS Data Brief."},{"issue":"1","key":"10.1016\/j.biopha.2025.118243_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-023-00435-4","article-title":"Child and adolescent obesity","volume":"9","author":"Lister","year":"2023","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2025.118243_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.706978","article-title":"Obesity: epidemiology, pathophysiology, and therapeutics","volume":"12","author":"Lin","year":"2021","journal-title":"Front Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118243_bib4","article-title":"Obesity as a Neuroendocrine Reprogramming","volume":"57","author":"Ghanemi","year":"2021","journal-title":"Med. (Kaunas. )"},{"issue":"5","key":"10.1016\/j.biopha.2025.118243_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bluher","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118243_bib6","article-title":"The effectiveness of nutritional strategies in the treatment and management of obesity: a systematic review","volume":"15","author":"Adeola","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.biopha.2025.118243_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102759","article-title":"A systematic review on the effectiveness of diet and exercise in the management of obesity","volume":"17","author":"Olateju","year":"2023","journal-title":"Diabetes Metab. Syndr."},{"issue":"1","key":"10.1016\/j.biopha.2025.118243_bib8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2025.118243_bib9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3389\/fnins.2017.00643","article-title":"Molecular mechanisms of antipsychotic drug-induced diabetes","volume":"11","author":"Chen","year":"2017","journal-title":"Front Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118243_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000114744","article-title":"Effects of long-term L-dopa therapy on carbohydrate metabolism in patients with Parkinson's disease","volume":"14","author":"Rosati","year":"1976","journal-title":"Eur. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118243_bib11","first-page":"55","article-title":"Does bromocriptine improve glycemic control of obese type-2 diabetics?","volume":"62","author":"Aminorroaya","year":"2004","journal-title":"Horm. Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118243_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0253-7613.56070","article-title":"Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes","volume":"41","author":"Mahajan","year":"2009","journal-title":"Indian J. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2025.118243_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000357810","article-title":"Effect of cabergoline on metabolism in prolactinomas","volume":"98","author":"Auriemma","year":"2013","journal-title":"Neuroendocrinology"},{"issue":"44","key":"10.1016\/j.biopha.2025.118243_bib14","doi-asserted-by":"crossref","first-page":"36824","DOI":"10.1074\/jbc.M505560200","article-title":"Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion","volume":"280","author":"Rubi","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2025.118243_bib15","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/en.2009-0996","article-title":"Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance","volume":"151","author":"Garcia-Tornadu","year":"2010","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.biopha.2025.118243_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025537","article-title":"Dopamine receptors in human adipocytes: expression and functions","volume":"6","author":"Borcherding","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118243_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101241","article-title":"Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes","volume":"51","author":"Tavares","year":"2021","journal-title":"Mol. Metab."},{"issue":"8","key":"10.1016\/j.biopha.2025.118243_bib18","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.metabol.2009.11.015","article-title":"Hepatic mitochondrial energetics during catch-up fat after caloric restriction","volume":"59","author":"Crescenzo","year":"2010","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.biopha.2025.118243_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00003088-200342070-00003","article-title":"Clinical pharmacokinetics of cabergoline","volume":"42","author":"Del Dotto","year":"2003","journal-title":"Clin. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118243_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0404.2005.00514.x","article-title":"Efficacy and safety of high-dose cabergoline in Parkinson's disease","volume":"113","author":"Odin","year":"2006","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.biopha.2025.118243_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"issue":"5639","key":"10.1016\/j.biopha.2025.118243_bib22","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/270725a0","article-title":"Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle","volume":"270","author":"Yaffe","year":"1977","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.biopha.2025.118243_bib23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1159\/000512685","article-title":"Cortisol circadian rhythm and insulin resistance in muscle: effect of dosing and timing of hydrocortisone exposure on insulin sensitivity in synchronized muscle cells","volume":"111","author":"Negri","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.biopha.2025.118243_bib24","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.biopha.2025.118243_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s12020-016-1079-2","article-title":"Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study","volume":"56","author":"Pivonello","year":"2017","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.biopha.2025.118243_bib26","doi-asserted-by":"crossref","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2025.118243_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-319-48382-5_12","article-title":"Insulin resistance, obesity and lipotoxicity","volume":"960","author":"Yazici","year":"2017","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.biopha.2025.118243_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","article-title":"Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease","volume":"7","author":"Chait","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118243_bib29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.drudis.2021.11.001","article-title":"Obesity and insulin resistance: pathophysiology and treatment","volume":"27","author":"Tong","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.biopha.2025.118243_bib30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1210\/endo-89-5-1295","article-title":"Inhibition of insulin secretion by serotonin and dopamine: species variation","volume":"89","author":"Quickel","year":"1971","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.biopha.2025.118243_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1210\/jcem-44-1-196","article-title":"The effect of dopamine infusion on insulin and glucagon secretion in man","volume":"44","author":"Leblanc","year":"1977","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.biopha.2025.118243_bib32","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12020-023-03525-1","article-title":"Subcutaneous adipose tissue dopamine D2 receptor is increased in prediabetes and T2D","volume":"83","author":"Vranic","year":"2024","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.biopha.2025.118243_bib33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1194\/jlr.M081000","article-title":"Dopamine D2 receptor upregulates leptin and IL-6 in adipocytes","volume":"59","author":"Wang","year":"2018","journal-title":"J. Lipid Res"},{"issue":"10-11","key":"10.1016\/j.biopha.2025.118243_bib34","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00702-003-0059-x","article-title":"Dopamine receptor agonists in the therapy of Parkinson's disease","volume":"111","author":"Foley","year":"2004","journal-title":"J. Neural Transm."},{"issue":"6","key":"10.1016\/j.biopha.2025.118243_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1530\/EC-16-0051","article-title":"Bromocriptine and insulin sensitivity in lean and obese subjects","volume":"5","author":"Bahler","year":"2016","journal-title":"Endocr. Connect"},{"issue":"6","key":"10.1016\/j.biopha.2025.118243_bib36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diacare.19.6.667","article-title":"Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects","volume":"19","author":"Cincotta","year":"1996","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.biopha.2025.118243_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3810\/pgm.2012.09.2598","article-title":"Focusing on cardiovascular disease in type 2 diabetes mellitus: an introduction to bromocriptine QR","volume":"124","author":"Bell","year":"2012","journal-title":"Post. Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.118243_bib38","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.1152\/ajpendo.00325.2019","article-title":"Bromocriptine improves glucose tolerance independent of circadian timing, prolactin, or the melanocortin-4 receptor","volume":"318","author":"Framnes-DeBoer","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.biopha.2025.118243_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22116142","article-title":"Time-of-day-dependent effects of bromocriptine to ameliorate vascular pathology and metabolic syndrome in shr rats held on high fat diet","volume":"22","author":"Ezrokhi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1-3","key":"10.1016\/j.biopha.2025.118243_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4889(98)00092-5","article-title":"Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob\/ob mice","volume":"1405","author":"Liang","year":"1998","journal-title":"Biochim Biophys. Acta"},{"issue":"12","key":"10.1016\/j.biopha.2025.118243_bib41","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.bcp.2010.01.029","article-title":"The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells","volume":"79","author":"de Leeuw van Weenen","year":"2010","journal-title":"Biochem Pharm."},{"issue":"40","key":"10.1016\/j.biopha.2025.118243_bib42","article-title":"Effects of cabergoline on blood glucose levels in type 2 diabetic patients: a double-blind controlled clinical trial","volume":"95","author":"Bahar","year":"2016","journal-title":"Med. (Baltim. )"},{"issue":"6","key":"10.1016\/j.biopha.2025.118243_bib43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/cen.12204","article-title":"Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels","volume":"79","author":"Ciresi","year":"2013","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118243_bib44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000371851","article-title":"Effect of chronic cabergoline treatment and testosterone replacement on metabolism in male patients with prolactinomas","volume":"101","author":"Auriemma","year":"2015","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.biopha.2025.118243_bib45","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1365-2265.2007.02973.x","article-title":"Body fat in nonobese women with prolactinoma treated with dopamine agonists","volume":"67","author":"Naliato","year":"2007","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118243_bib46","first-page":"624","article-title":"The laboratory rat: relating its age with human's","volume":"4","author":"Sengupta","year":"2013","journal-title":"Int J. Prev. Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.118243_bib47","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1038\/s41467-020-16882-6","article-title":"Circadian regulation of hedonic appetite in mice by clocks in dopaminergic neurons of the VTA","volume":"11","author":"Koch","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118243_bib48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1475-2840-13-103","article-title":"Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?","volume":"13","author":"Fisman","year":"2014","journal-title":"Cardiovasc Diabetol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118243_bib49","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00109-002-0378-7","article-title":"Adiponectin: a link between excess adiposity and associated comorbidities?","volume":"80","author":"Ukkola","year":"2002","journal-title":"J. Mol. Med (Berl. )"},{"issue":"9","key":"10.1016\/j.biopha.2025.118243_bib50","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2174\/138955710791608325","article-title":"The role of the novel adipocyte-derived protein adiponectin in human disease: an update","volume":"10","author":"Diez","year":"2010","journal-title":"Mini Rev. Med Chem."},{"issue":"4","key":"10.1016\/j.biopha.2025.118243_bib51","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1097-2765(00)80210-5","article-title":"PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance","volume":"4","author":"Kubota","year":"1999","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.biopha.2025.118243_bib52","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/sj.ijo.0801496","article-title":"Adipose tissue growth and differentiation: view from the chair","volume":"24","author":"Lau","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"3","key":"10.1016\/j.biopha.2025.118243_bib53","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ijcard.2007.12.087","article-title":"Effect of weight loss on coronary circulation and adiponectin levels in obese women","volume":"134","author":"Coppola","year":"2009","journal-title":"Int. J. Cardiol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118243_bib54","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.2337\/db18-er12a","article-title":"Erratum. The adiponectin paradox for all-cause and cardiovascular mortality","volume":"67","author":"Menzaghi","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2025.118243_bib55","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fnins.2018.01027","article-title":"The role of leptin and adiponectin in obesity-associated cognitive decline and Alzheimer's disease","volume":"12","author":"Forny-Germano","year":"2018","journal-title":"Front Neurosci."},{"issue":"8","key":"10.1016\/j.biopha.2025.118243_bib56","doi-asserted-by":"crossref","first-page":"bvac095","DOI":"10.1210\/jendso\/bvac095","article-title":"Adipose and skeletal muscle expression of adiponectin and liver receptor homolog-1 with weight loss and aerobic exercise","volume":"6","author":"Ryan","year":"2022","journal-title":"J. Endocr. Soc."},{"issue":"2","key":"10.1016\/j.biopha.2025.118243_bib57","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cmet.2014.06.003","article-title":"Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction","volume":"20","author":"Cawthorn","year":"2014","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.biopha.2025.118243_bib58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/21623945.2016.1149269","article-title":"Inside out: bone marrow adipose tissue as a source of circulating adiponectin","volume":"5","author":"Scheller","year":"2016","journal-title":"Adipocyte"},{"key":"10.1016\/j.biopha.2025.118243_bib59","doi-asserted-by":"crossref","first-page":"15253","DOI":"10.1038\/ncomms15253","article-title":"Impact of fat mass and distribution on lipid turnover in human adipose tissue","volume":"8","author":"Spalding","year":"2017","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2025.118243_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092358","article-title":"Adipose tissue dysfunction as determinant of obesity-associated metabolic complications","volume":"20","author":"Longo","year":"2019","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225004378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225004378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T11:49:27Z","timestamp":1754653767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225004378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":60,"alternative-id":["S0753332225004378"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118243","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cabergoline counteracts adipose and skeletal muscle lipid accumulation: A novel therapeutic approach to obesity?","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118243"}}